MinMi Holdings (MI&MI HOLDINGS) is a specialized company that plans medical and aesthetic products, operates brands, and manages global distribution for the global medical aesthetic market. Based in Korea, the company collaborates with partners across Europe, the Middle East, Russia, and Asia, implementing product and brand strategies optimized for international markets. Going beyond simple distribution, MinMi Holdings possesses comprehensive business capabilities encompassing product positioning, exhibition strategy, and export structure design, and has built a competitive product lineup across the medical aesthetic sector, including fillers, skin boosters, and aesthetic solutions.
MinMi Holdings continuously distributes and exports medical and medical aesthetic products from Korea to major overseas markets such as China, the United States, and Australia. In the Chinese and Australian markets, the company has established stable supply structures through collaboration with local distribution partners, while in the U.S. market it is expanding brand awareness through a phased market entry strategy that considers regulatory environments and market characteristics. By tailoring product configurations to country-specific market needs and actively participating in exhibitions and buyer meetings, MinMi Holdings has accumulated tangible export performance, which now serves as key reference data for future global expansion.
At this exhibition, MinMi Holdings presents a core lineup of medical aesthetic products selected based on its actual overseas distribution experience. The exhibited products are organized with a focus on clinical applicability, product stability, and global market suitability, offering buyers a broad range of choices through a portfolio that spans fillers, skin boosters, and aesthetic solutions. Through this approach, the company aims to emphasize its strengths as a comprehensive medical aesthetic solutions provider rather than a single-product supplier.
One of MinMi Holdings’ flagship products is PeachFill, a medical aesthetic collagen injectable planned specifically for global markets. Positioned primarily for overseas exhibitions and export, PeachFill is designed to support global buyer consultations and international market entry through stable quality and a practice-oriented product configuration, and is utilized within phased market entry strategies that reflect country-specific regulatory environments.
The PILLOX lineup is an aesthetic solution series focused on facial contour management and regenerative care. The PILLOX Premium V-Line Lipolysis Solution is a professional product planned for facial line shaping and localized contour management, and is introduced primarily within the high-demand contour management category of the global aesthetic market.
PILLOX Shining MediHealer 250 is an aesthetic solution based on a regenerative cosmeceutical concept. With a composite formulation including PDRN, hyaluronic acid, and collagen, it is designed for combined use with various treatment programs and is introduced at the exhibition as a representative regenerative care product within the PILLOX lineup.
2XSome is a premium exosome-based skin booster product that adopts a dual-configuration system consisting of powder and an activation diluent. Designed for skin condition care, it is presented as a next-generation strategic skin booster with flexibility for application across various treatment areas.
Softlips Touch is a hyaluronic acid filler designed specifically for lip applications. Featuring a formulation that accounts for lip movement and sensitivity while enabling uniform volume expression, it represents a high-demand lip filler category product in global markets and has attracted strong interest from buyers.
Through this exhibition, MinMi Holdings aims to identify new buyers and strengthen partnerships, particularly in China, the United States, and Australia. China remains a key market with steadily growing medical aesthetic demand, where the company is exploring collaboration with local distributors. In the U.S. market, MinMi Holdings is pursuing phased cooperation with partners that possess networks of medical professionals and aesthetic clinics. In Australia, securing long-term distribution partners is set as a primary objective, based on a stable regulatory environment and demand for premium aesthetic products.
Starting in 2026, MinMi Holdings plans to expand its global market presence through active participation in overseas exhibitions. Rather than limiting its focus to specific countries, the company intends to strategically select exhibitions by comprehensively evaluating market growth potential, regulatory conditions, and buyer demand. Through this approach, MinMi Holdings aims to discover new buyers, strengthen cooperation with existing partners, and build a long-term global distribution network, expanding its global business in a phased and stable manner.
Meanwhile, MinMi Holdings will participate in KIMES 2026, showcasing its core medical aesthetic products—including PeachFill, PILLOX, Queen Solution, 2XSome, and Softlips Touch—and actively exploring practical collaboration opportunities with global buyers.